Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02495584
Other study ID # 13/NI/0091
Secondary ID
Status Completed
Phase N/A
First received May 11, 2015
Last updated January 14, 2016
Start date September 2014
Est. completion date October 2015

Study information

Verified date January 2016
Source University of Ulster
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Vitamin D insufficiency has become a global concern, with low vitamin D status associated with bone disorders, cardiovascular disease and certain cancers. The United Kingdom (UK) and Ireland are at particular risk of vitamin D deficiency owing to the northerly latitude, increased use of sunscreen, decreased sun exposure and a high level of cloud cover. A recent survey in the UK showed that more than 50% of UK adults have insufficient vitamin D status, with lower levels noted in the winter months. Variations in vitamin D status have been known to vary between summer and winter, owing to our northern latitude (52-55°N) the Ultraviolet (UV)-B intensity in Northern Ireland is inadequate to promote the dermal synthesis of vitamin D during the winter months, causing us to rely on dietary sources. The aim of this intervention is to investigate the main effects of vitamin D3-fortified milk and supplemental vitamin D3 on vitamin D status and functional health outcomes during the winter, and how this intervention will affect subsequent dermal synthesis of vitamin D from UV exposure. Participants will be recruited from the local community. Blood samples will be collected from each participant at two timepoints (September/October and March/April). Pre- and post-intervention blood pressure, grip strength, height, weight, waist and hip circumferences will be measured, in addition participants will undergo a dual energy x-ray absorptiometry (DXA) scan to assess body composition and bone mineral density. Information on general health, lifestyle, physical activity, dietary intake and typical behaviours in the sun will be collected. Following the dietary intervention, a subset of participants will be invited to participate in a follow-up study, examining UV exposure during the summer months, when they will wear a personal wrist dosimeter for 1 month, complete a sun dairy and provide 2 additional blood samples.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date October 2015
Est. primary completion date October 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- 20-40 years old

- Apparently healthy

- Living on the island of Ireland

Exclusion Criteria:

- Below 20 years and aged 40 years or above

- Not living on the island of Ireland

- Pregnant or lactating women and those planning to become pregnant

- Individuals who have been taking a vitamin D or calcium containing supplement in the previous three months

- Those with food intolerances or allergies that would affect their ability to consume study milk

- Individuals following a diet which excludes milk (e.g. vegans)

- Those with a diagnosed chronic medical condition or on prescribed medication known to effect vitamin D metabolism

- Those who are planning a sun holiday during the winter months (Oct-Mar)

- Adults with learning, or any other difficulties that would prevent them from completing the study protocol

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention


Intervention

Dietary Supplement:
Fortified milk (10µg vitamin D3)

Unfortified milk (placebo)

10µg vitamin D3 supplement

Placebo supplement


Locations

Country Name City State
United Kingdom Human Intervention Studies Unit Coleraine

Sponsors (4)

Lead Sponsor Collaborator
University of Ulster Agri-food & Biosciences Institute, Center for Nutrition and Health, RIVM (The Netherlands), Dairy Council for Northern Ireland

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other UV exposure (follow-up) Assessed by UV wrist monitors 8 weeks post-intervention (32-40 weeks) No
Primary Change in vitamin D status (25-hydroxyvitamin D serum concentration) Blood analysis Baseline + post-intervention (24weeks) No
Secondary Change in body composition Assessed by dual energy X-ray absorptiometry (DXA) Baseline + post-intervention (24weeks) No
Secondary Change in muscle strength Assessed by grip strength Baseline + post-intervention (24weeks) No
Secondary Change in inflammation status Blood analysis Baseline + post-intervention (24weeks) No
Secondary Change in lipid profile Blood analysis Baseline + post-intervention (24weeks) No
Secondary Change in glucose levels Blood analysis Baseline + post-intervention (24weeks) No
Secondary Change in insulin concentrations Blood analysis Baseline + post-intervention (24weeks) No